Clinical Trial Update: Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH [Phase 1, Phase 2]

View source ↗

Summary

An update on an ongoing Phase 1/2 trial evaluating selected mesenchymal stromal cells to reduce liver inflammation in patients with primary sclerosing cholangit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis
• Sclerosing Cholangitis

Drugs mentioned

• Selected Mesenchymal Stromal Cells

Snippet

Sponsor: University of Birmingham | Conditions: Cholangitis, Sclerosing, Hepatitis, Autoimmune | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING